Published in Autoimmun Rev on August 12, 2008
Role of sulfatide in normal and pathological cells and tissues. J Lipid Res (2012) 1.27
NKT-cell subsets: promoters and protectors in inflammatory liver disease. J Hepatol (2013) 1.01
Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection. Clin Dev Immunol (2012) 0.93
Diagnosis and therapeutic options for peripheral vasculitic neuropathy. Ther Adv Musculoskelet Dis (2015) 0.82
HCV-related central and peripheral nervous system demyelinating disorders. Inflamm Allergy Drug Targets (2014) 0.77
Hepatitis C virus and autoimmunity. Auto Immun Highlights (2010) 0.77
Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell (1997) 8.23
A new class of membrane-bound chemokine with a CX3C motif. Nature (1997) 7.87
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry (2008) 5.35
Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature (1998) 4.03
CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med (1997) 2.24
A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol (1998) 2.21
delta-catenin, an adhesive junction-associated protein which promotes cell scattering. J Cell Biol (1999) 2.07
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum (2012) 1.96
ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia. Leukemia (2012) 1.68
The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics. Funct Neurol (2009) 1.62
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. Br J Cancer (2009) 1.48
Is it possible to obtain a presurgical Lasmar score for hysteroscopic myomectomy by ultrasound alone? Ultrasound Obstet Gynecol (2012) 1.43
Complement receptor (CR1) and IgG or IgA on erythrocytes and in circulating immune complexes in patients with glomerulonephritis. Nephrol Dial Transplant (1989) 1.42
Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role. Br J Dermatol (2008) 1.42
Chlamydia trachomatis infection in children with wheezing simulating asthma. Lancet (1992) 1.42
Fine-needle percutaneous biopsy of renal masses with helical CT guidance. Radiology (2000) 1.38
Transmission of prions. Proc Natl Acad Sci U S A (2002) 1.36
Anion conductance behavior of the glutamate uptake carrier in salamander retinal glial cells. J Neurosci (1996) 1.34
Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int (1998) 1.32
Spatially segregated control of Ca2+ release in developing skeletal muscle of mice. J Physiol (1999) 1.31
Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells. J Biol Chem (1997) 1.27
Peroxynitrite inhibits glutamate transporter subtypes. J Biol Chem (1996) 1.21
In situ activation of the type 2 ryanodine receptor in pancreatic beta cells requires cAMP-dependent phosphorylation. Proc Natl Acad Sci U S A (1998) 1.21
CT-guided percutaneous transthoracic biopsy in the diagnosis of mediastinal masses: evaluation of 73 procedures. Radiol Med (2008) 1.16
Harrington instrumentation and arthrodesis for idiopathic scoliosis. A twenty-one-year follow-up. J Bone Joint Surg Am (1990) 1.15
The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes. Leukemia (2012) 1.14
Nonoperative management of pancreatic injuries in children. J Pediatr Surg (1998) 1.14
Screening for chronic cerebrospinal venous insufficiency (CCSVI) using ultrasound--recommendations for a protocol. Int Angiol (2011) 1.12
The role of glutamate transporters in glutamate homeostasis in the brain. J Exp Biol (1997) 1.12
First evidence of peste des petits ruminants (PPR) virus circulation in Algeria (Sahrawi territories): outbreak investigation and virus lineage identification. Transbound Emerg Dis (2011) 1.11
B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice. Proc Natl Acad Sci U S A (2001) 1.10
Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun Rev (2011) 1.10
Gluten-induced experimental IgA glomerulopathy. Lab Invest (1989) 1.09
Liposome-associated retinoic acid. Increased in vitro antiproliferative effects on neoplastic cells. FEBS Lett (1990) 1.09
NEMO syndrome (incontinentia pigmenti) and systemic lupus erythematosus: a new disease association. Lupus (2012) 1.08
Transmission of prions. J Infect Dis (2002) 1.08
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells. Leukemia (2012) 1.07
Crystal and molecular structure of the bovine alpha-chymotrypsin-eglin c complex at 2.0 A resolution. J Mol Biol (1992) 1.06
CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells. Leukemia (2010) 1.06
Characterization and mapping of the 12 kDa FK506-binding protein (FKBP12)-binding site on different isoforms of the ryanodine receptor and of the inositol 1,4,5-trisphosphate receptor. Biochem J (2001) 1.05
Value of MR venography for detection of internal jugular vein anomalies in multiple sclerosis: a pilot longitudinal study. AJNR Am J Neuroradiol (2011) 1.05
IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis. Clin Exp Immunol (1984) 1.05
[Bladder metastasis of malignant melanoma: a case report and review of literature]. Prog Urol (2008) 1.05
Physiological and pathological operation of glutamate transporters. Prog Brain Res (1998) 1.04
Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study. Int Angiol (2010) 1.03
Effects of a gluten-free diet in primary IgA nephropathy. Clin Nephrol (1990) 1.03
HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol (2008) 1.03
Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities. J Thromb Haemost (2012) 1.03
Incidence of HIV type 1 infection, antiretroviral drug resistance, and molecular characterization in newly diagnosed individuals in Argentina: A Global Fund Project. AIDS Res Hum Retroviruses (2010) 1.02
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit? Br J Cancer (2008) 1.01
Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors. Lab Invest (1993) 1.00
Neuronal and glial glutamate transporters possess an SH-based redox regulatory mechanism. Eur J Neurosci (1997) 1.00
Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology (1993) 1.00
Influence of formulation and process parameters on pellet production by powder layering technique. AAPS PharmSciTech (2000) 0.99
Screening for chronic cerebrospinal venous insufficiency (CCSVI) using ultrasound: recommendations for a protocol. Funct Neurol (2012) 0.99
Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia. Leukemia (2004) 0.99
Hemodynamic patterns of chronic cerebrospinal venous insufficiency in multiple sclerosis. Correlation with symptoms at onset and clinical course. Int Angiol (2010) 0.98
Hysteroscopic management of large symptomatic submucous uterine myomas. J Minim Invasive Gynecol (2010) 0.97
Mediterranean diet and primary IgA nephropathy. Clin Nephrol (1986) 0.97
Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review. BJOG (2013) 0.97
Diagnosis and management of duodenal injuries in children. J Pediatr Surg (1997) 0.97
Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kappa B activity. Virology (1995) 0.96
Crystal structure of the bovine alpha-chymotrypsin:Kunitz inhibitor complex. An example of multiple protein:protein recognition sites. J Mol Recognit (1997) 0.96
Radioimmunoassay to detect antitransglutaminase autoantibodies is the most sensitive and specific screening method for celiac disease. Am J Gastroenterol (2001) 0.96
The gas 5 gene shows four alternative splicing patterns without coding for a protein. Gene (2000) 0.96
Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers. Autoimmun Rev (2012) 0.96
HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid. FEBS Lett (1997) 0.95
Dietary antigens and primary immunoglobulin A nephropathy. J Am Soc Nephrol (1992) 0.95
Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile. Lupus (2012) 0.94
Intracellular Ca(2+) release channels in evolution. Curr Opin Genet Dev (2000) 0.94
Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug. Biochem Pharmacol (2001) 0.92
Plasma exchange in progressive primary IgA nephropathy. Int J Artif Organs (1985) 0.92
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Ann Oncol (2011) 0.92
Is chronic fatigue the symptom of venous insufficiency associated with multiple sclerosis? A longitudinal pilot study. Int Angiol (2010) 0.92
Autoimmune events during interferon beta-1b treatment for multiple sclerosis. J Neurol Sci (1999) 0.92
Interleukin-15 activates proinflammatory and antimicrobial functions in polymorphonuclear cells. Infect Immun (1998) 0.91
Incidence of biopsy-proven primary glomerulonephritis in an Italian province. Am J Kidney Dis (1996) 0.91
Experimental IgA nephropathy secondary to hepatocellular injury induced by dietary deficiencies and heavy alcohol intake. Lab Invest (1994) 0.91
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. Ann Oncol (2009) 0.91
Proteinase inhibitors from the European medicinal leech Hirudo medicinalis: structural, functional and biomedical aspects. Mol Aspects Med (1995) 0.90
Proton NMR and photochemically induced dynamic nuclear polarization studies of peptide fragments obtained by controlled proteolysis of mouse epidermal growth factor. J Biol Chem (1986) 0.90
Correlation between cytomegalovirus infection and Raynaud's phenomenon in lupus nephritis. Nephron (1999) 0.90
Do IgA antigliadin and IgA antiendomysium antibodies show there is latent coeliac disease in primary IgA nephropathy? Gut (1992) 0.90
E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia. Leukemia (2011) 0.90
Colour-coded Doppler sonography in monitoring native kidney biopsies. Nephrol Dial Transplant (1994) 0.90
Magnetic resonance imaging examination of denervated muscle. Comput Radiol (1987) 0.90
Knee motion following multiple soft-tissue releases in ambulatory patients with cerebral palsy. J Pediatr Orthop (1992) 0.89
Interferon alpha-2a treatment of relapsing-remitting multiple sclerosis: disease activity resumes after stopping treatment. Neurology (1996) 0.89
Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA-associated idiopathic systemic vasculitis with or without overt renal involvement. Clin Exp Rheumatol (2008) 0.89
The murine cytomegalovirus immediate-early 1 protein stimulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 promoter. Virus Res (1996) 0.89